172 related articles for article (PubMed ID: 6737054)
1. Prognostic importance of cellular differentiation in medulloblastoma of childhood.
Packer RJ; Sutton LN; Rorke LB; Littman PA; Sposto R; Rosenstock JG; Bruce DA; Schut L
J Neurosurg; 1984 Aug; 61(2):296-301. PubMed ID: 6737054
[TBL] [Abstract][Full Text] [Related]
2. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors.
Rorke LB
J Neuropathol Exp Neurol; 1983 Jan; 42(1):1-15. PubMed ID: 6296325
[TBL] [Abstract][Full Text] [Related]
3. [Glial fibrillary acidic protein and neurofilament protein in medulloblastoma].
Tohyama T; Kubo O; Katahira M; Sakairi M; Tajika T; Tajika Y; Kitamura K
No Shinkei Geka; 1988 Oct; 16(11):1243-50. PubMed ID: 3145467
[TBL] [Abstract][Full Text] [Related]
4. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment.
Stensvold E; Krossnes BK; Lundar T; Due-Tønnessen BJ; Frič R; Due-Tønnessen P; Bechensteen AG; Myklebust TÅ; Johannesen TB; Brandal P
Acta Oncol; 2017 May; 56(5):698-705. PubMed ID: 28325133
[TBL] [Abstract][Full Text] [Related]
5. Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors.
Woodburn RT; Azzarelli B; Montebello JF; Goss IE
J Neurooncol; 2001 Mar; 52(1):57-62. PubMed ID: 11451203
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro models of medulloblastomas and other primitive neuroectodermal brain tumors of childhood.
Trojanowski JQ; Fung KM; Rorke LB; Tohyama T; Yachnis AT; Lee VM
Mol Chem Neuropathol; 1994; 21(2-3):219-39. PubMed ID: 8086035
[TBL] [Abstract][Full Text] [Related]
7. Children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor in Norway from 1974 through 2013: Unexplainable regional differences in survival.
Stensvold E; Myklebust TÅ; Cappelen J; Due-Tønnessen BJ; Due-Tønnessen P; Kepka A; Johannesen TB; Krossnes B; Lundar T; Maric S; Miletic H; Moholdt V; Myrmel KS; Nordberg T; Rydland J; Stokland T; Solem K; Solheim O; Torsvik I; Wikran GC; Zeller B; Wesenberg F; Bechensteen AG; Brandal P
Pediatr Blood Cancer; 2019 Oct; 66(10):e27910. PubMed ID: 31264356
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ
Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550
[TBL] [Abstract][Full Text] [Related]
9. Medulloblastoma/primitive neuroectodermal tumor in 45 adults.
Peterson K; Walker RW
Neurology; 1995 Mar; 45(3 Pt 1):440-2. PubMed ID: 7898692
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
[TBL] [Abstract][Full Text] [Related]
11. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
[TBL] [Abstract][Full Text] [Related]
12. p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis.
Jaros E; Lunec J; Perry RH; Kelly PJ; Pearson AD
Br J Cancer; 1993 Oct; 68(4):801-7. PubMed ID: 8398711
[TBL] [Abstract][Full Text] [Related]
13. An immunohistochemical analysis of medulloblastoma and PNET with emphasis on N-myc protein expression.
Moriuchi S; Shimizu K; Miyao Y; Hayakawa T
Anticancer Res; 1996; 16(5A):2687-92. PubMed ID: 8917371
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblastomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal derivation.
Smits A; van Grieken D; Hartman M; Lendahl U; Funa K; Nistér M
Lab Invest; 1996 Jan; 74(1):188-98. PubMed ID: 8569181
[TBL] [Abstract][Full Text] [Related]
15. High microvessel density in primitive neuroectodermal brain tumors of childhood.
Grotzer MA; Wiewrodt R; Janss AJ; Zhao H; Cnaan A; Sutton LN; Rorke LB; Phillips PC
Neuropediatrics; 2001 Apr; 32(2):75-9. PubMed ID: 11414647
[TBL] [Abstract][Full Text] [Related]
16. Incidence and survival of children and young people with central nervous system embryonal tumours in the North of England, 1990-2013.
Fairley L; Picton SV; McNally RJ; Bailey S; McCabe MG; Feltbower RG
Eur J Cancer; 2016 Jul; 61():36-43. PubMed ID: 27151553
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors.
Bakish J; Hargrave D; Tariq N; Laperriere N; Rutka JT; Bouffet E
Cancer; 2003 Sep; 98(5):1014-20. PubMed ID: 12942570
[TBL] [Abstract][Full Text] [Related]
18. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
[TBL] [Abstract][Full Text] [Related]
19. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results.
McNeil DE; Coté TR; Clegg L; Rorke LB
Med Pediatr Oncol; 2002 Sep; 39(3):190-4. PubMed ID: 12210449
[TBL] [Abstract][Full Text] [Related]
20. Low-grade bone lesions in survivors of childhood medulloblastoma/primitive neuroectodermal tumor.
Koral K; Roy D; Timmons CF; Gargan L; Bowers DC
Acad Radiol; 2012 Jan; 19(1):35-9. PubMed ID: 22054800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]